Skip to content

Seahorse, founded in 2001, was a leading provider of instruments and assay kits for measuring cell metabolism and bioenergetics and elucidating the role of these in neurodegeneration, aging, cancer, cardiovascular, and myriad other biological processes. The company was acquired by Agilent Technologies for $235M in 2015.

Latest News from Seahorse Bioscience